Johan Gibcus to MicroRNAs
This is a "connection" page, showing publications Johan Gibcus has written about MicroRNAs.
Connection Strength
0.589
-
Gibcus JH, Kroesen BJ, Koster R, Halsema N, de Jong D, de Jong S, Poppema S, Kluiver J, Diepstra A, van den Berg A. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma. J Pathol. 2011 Dec; 225(4):609-17.
Score: 0.250
-
Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, M?ller P, Poppema S, Kroesen BJ, van den Berg A. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia. 2009 Feb; 11(2):167-76.
Score: 0.208
-
Kluiver J, Gibcus JH, Hettinga C, Adema A, Richter MK, Halsema N, Slezak-Prochazka I, Ding Y, Kroesen BJ, van den Berg A. Rapid generation of microRNA sponges for microRNA inhibition. PLoS One. 2012; 7(1):e29275.
Score: 0.064
-
Tan LP, Wang M, Robertus JL, Schakel RN, Gibcus JH, Diepstra A, Harms G, Peh SC, Reijmers RM, Pals ST, Kroesen BJ, Kluin PM, Poppema S, van den Berg A. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab Invest. 2009 Jun; 89(6):708-16.
Score: 0.053
-
Koster R, di Pietro A, Timmer-Bosscha H, Gibcus JH, van den Berg A, Suurmeijer AJ, Bischoff R, Gietema JA, de Jong S. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest. 2010 Oct; 120(10):3594-605.
Score: 0.015